Loading...
NYSE: RVTY
Revvity, Inc.
Healthcare · Medical - Diagnostics & Research
●S&P 500 since 1985
Market Cap
$9.69B
52w High
$118.30
52w Low
$81.36
P/E
40.02
Volume
522.02K
Outstanding Shares
113.38M
Company profile
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide.
CEOPrahlad R. Singh
SectorHealthcare
IndustryMedical - Diagnostics & Research
Employees11,000
IPO dateJul 6, 1965
Valuation
Forward P/E—
EV/EBITDA20.51
Enterprise value$13.59B
Stock splits
Jun 4, 20012:1
May 11, 19922:1
Feb 2, 19822:1
Feb 4, 19802:1
Profitability & growth
Revenue growth5.85%
Gross margin50.16%▲10.57%vs FY2024
Operating margin13.04%▼16.20%vs FY2024
ROE3.33%▼13.61%vs FY2024
Analyst consensus
RatingBuy
Target price$115.14▲34.77%
17
Buy
12
Hold
0
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Apr 27, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$1.18
$1.14
Q3FY25
ActualEst.
$1.18
$1.14
Q4FY25
ActualEst.
$1.70
$1.57
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$720.28M
$699.89M
Q3FY25
ActualEst.
$698.95M
$699.36M
Q4FY25
ActualEst.
$772.06M
$704.81M
Q1FY26
Next Est.
—